Titanium particles activate toll-like receptor 4 independently of lipid rafts in RAW264.7 murine macrophages.
Adherent pathogen-associated molecular patterns (PAMPs) act through toll-like receptor 2 (TLR2) and TLR4 to increase the biological activity of orthopedic wear particles in cell culture and animal models of implant loosening. This study tested whether this is dependent on TLR association with lipid rafts as reported for the response to soluble TLR ligands. For this purpose, RAW264.7 murine macrophages were activated by exposure to titanium particles with adherent PAMPs, soluble lipopolysaccharide (LPS), soluble lipotecichoic acid (LTA), or heat-killed bacteria that had been extensively washed to remove soluble PAMPs. Lipid rafts were isolated by two independent methods and the location of TLR4 and TLR2 was analyzed by Western blotting. The cognate TLRs associated with lipid rafts when the macrophages were activated with soluble LPS and LTA but not after stimulation with either titanium particles with adherent PAMPs or heat-killed bacteria. The lipid raft disruptor, methyl-β-cyclodextrin, dose-dependently inhibited TNF-α release in response to LPS but had no affect on TNF-α release in response to titanium particles with adherent PAMPs. We conclude, therefore, that titanium particles with adherent PAMPs and heat-killed bacteria activate TLR2 and TLR4 in macrophages without inducing either TLR to associate with lipid rafts. These results have important implications for the mechanisms of orthopedic implant loosening as well the mechanisms for TLR activation in other inflammatory situations.
Islam
Andrew S
AS
Department of Orthopaedics, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio 44106-5000, USA. andrewislam@yahoo.com
Beidelschies
Michelle A
MA
Huml
Anne
A
Greenfield
Edward M
EM
D000818:Animals; D002460:Cell Line; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D021962:Membrane Microdomains / Q000187:drug effects*; D051379:Mice; D011475:Prosthesis Failure / Q000209:etiology*; D014025:Titanium / Q000009:adverse effects*; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D047392:beta-Cyclodextrins
C493486:Tlr2 protein, mouse; C493487:Tlr4 protein, mouse; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D014409:Tumor Necrosis Factor-alpha; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D014025:Titanium
J Orthop Res. 2002 Jan;20(1):1-8
11855378
J Biomed Mater Res A. 2007 Jun 15;81(4):1017-26
17415764
J Biomed Mater Res B Appl Biomater. 2005 Jan 15;72(1):179-85
15449253
Nat Immunol. 2010 May;11(5):373-84
20404851
J Leukoc Biol. 2009 Jun;85(6):905-10
19276179
J Am Acad Orthop Surg. 2008;16 Suppl 1:x-xi
18612024
Cell. 1992 Feb 7;68(3):533-44
1531449
Eur J Immunol. 2001 Nov;31(11):3153-64
11745332
J Orthop Res. 2007 Mar;25(3):361-9
17106883
Immunity. 1999 Oct;11(4):443-51
10549626
J Biol Chem. 2006 Oct 13;281(41):31002-11
16880211
J Cell Sci. 2002 Jun 15;115(Pt 12):2603-11
12045230
J Orthop Res. 2005 May;23(3):520-5
15885470
J Biol Chem. 2007 Feb 16;282(7):4669-4680
17164250
J Am Acad Orthop Surg. 2008;16 Suppl 1:S56-62
18612015
Nat Immunol. 2007 Jan;8(1):11-3
17179963
Biochem J. 2004 Jul 15;381(Pt 2):527-36
15040785
Biochem J. 1998 Sep 1;334 ( Pt 2):325-33
9716490
J Biol Chem. 2000 Jun 9;275(23):17221-4
10770957
J Orthop Res. 2005 Mar;23(2):376-83
15734251
J Exp Med. 2003 Oct 20;198(8):1225-35
14568981
Acta Orthop Scand. 2003 Dec;74(6):644-51
14763692
J Bone Miner Res. 2000 Dec;15(12):2391-401
11127204
Acta Orthop. 2006 Apr;77(2):177-97
16752278
Clin Orthop Relat Res. 2005 Aug;(437):25-30
16056022
J Bone Miner Res. 2001 Nov;16(11):2082-91
11697805
J Cell Physiol. 2007 Feb;210(2):428-35
17111383
Hypertension. 2006 Jan;47(1):74-80
16344372
J Biol Chem. 2010 Oct 15;285(42):32378-84
20729214
J Exp Med. 1999 Feb 15;189(4):615-25
9989976
J Biol Chem. 2004 Sep 24;279(39):40882-9
15247273
J Clin Invest. 2004 May;113(10):1482-9
15146246
Science. 1998 Dec 11;282(5396):2085-8
9851930
J Cell Physiol. 2008 Dec;217(3):652-66
18651635